These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32584134)

  • 21. Aberrant expression of microRNAs in peripheral blood mononuclear cells as candidate biomarkers in patients with axial spondyloarthritis.
    Li X; Lv Q; Tu L; Zhao M; Zhang P; Li Q; Wei Q; Cao S; Gu J
    Int J Rheum Dis; 2019 Jul; 22(7):1188-1195. PubMed ID: 30990253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between C-Reactive Protein to Albumin Ratio and Disease Activity in Patients with Axial Spondyloarthritis.
    Zhong Z; Huang Y; Liu Y; Chen J; Liu M; Huang Q; Zheng S; Guo X; Deng W; Li T
    Dis Markers; 2021; 2021():6642486. PubMed ID: 34234877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of sex and disease classification on patient-reported outcome measures in axial spondyloarthritis: a descriptive prospective cross-sectional study.
    Andreasen RA; Kristensen LE; Egstrup K; Baraliakos X; Strand V; Horn HC; Hansen IMJ; Christensen R; Ellingsen T
    Arthritis Res Ther; 2019 Oct; 21(1):221. PubMed ID: 31665083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation and reliability of translation of the ASAS Health Index in a Colombian Spanish-speaking population with spondyloarthritis.
    Bautista-Molano W; Landewé RBM; Kiltz U; Valle-Oñate R; van der Heijde D
    Clin Rheumatol; 2018 Nov; 37(11):3063-3068. PubMed ID: 30259248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single determination of C-reactive protein does not suffice to declare a patient with a diagnosis of axial spondyloarthritis 'CRP-negative'.
    Landewé R; Nurminen T; Davies O; Baeten D
    Arthritis Res Ther; 2018 Sep; 20(1):209. PubMed ID: 30217232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
    Kilic G; Kilic E; Ozgocmen S
    Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma heat shock protein 90 levels in patients with spondyloarthritis and their relation to structural changes: a cross-sectional study.
    Bubova K; Storkanova H; Oreska S; Spiritovic M; Hermankova B; Mintalova K; Gregova M; Husakova M; Horinkova J; Forejtova S; Gatterova J; Stolfa J; Komarc M; Vencovsky J; Pavelka K; Senolt L; Tomcik M
    Biomark Med; 2021 Jan; 15(1):5-13. PubMed ID: 33427496
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis.
    Hušáková M; Bay-Jensen AC; Forejtová Š; Zegzulková K; Tomčík M; Gregová M; Bubová K; Hořínková J; Gatterová J; Pavelka K; Siebuhr AS
    Sci Rep; 2019 Aug; 9(1):11218. PubMed ID: 31375691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
    Protopopov M; Sieper J; Haibel H; Listing J; Rudwaleit M; Poddubnyy D
    Arthritis Res Ther; 2017 Oct; 19(1):240. PubMed ID: 29065931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
    Kang KY; Jung JY; Hong YS; Ju JH; Park SH
    Clin Exp Rheumatol; 2017; 35(3):415-422. PubMed ID: 27974096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-radiographic axial spondyloarthritis.
    Kameda H; Kobayashi S; Tamura N; Kadono Y; Tada K; Yamamura M; Tomita T
    Mod Rheumatol; 2021 Mar; 31(2):277-282. PubMed ID: 32996809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis.
    Poddubnyy D; Conrad K; Haibel H; Syrbe U; Appel H; Braun J; Rudwaleit M; Sieper J
    Ann Rheum Dis; 2014 Dec; 73(12):2137-43. PubMed ID: 23956246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of serum fibroblast growth factor-23 in patients with axial spondyloarthritis and its association with sclerostin, inflammation, and spinal damage.
    Gercik O; Solmaz D; Coban E; Iptec BO; Avcioglu G; Bayindir O; Kabadayi G; Topal FE; Kozaci D; Akar S
    Rheumatol Int; 2019 May; 39(5):835-840. PubMed ID: 30968207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal Association Between Trabecular Bone Loss and Disease Activity in Axial Spondyloarthritis: A 4-year Prospective Study.
    Kang KY; Ju JH; Park SH; Hong YS
    J Rheumatol; 2020 Sep; 47(9):1330-1337. PubMed ID: 31732556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatigue in patients with spondyloarthritis associates with disease activity, quality of life and inflammatory bowel symptoms.
    Stebbings SM; Treharne GJ; Jenks K; Highton J
    Clin Rheumatol; 2014; 33(10):1467-74. PubMed ID: 24322832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between monocytes to lymphocytes ratio and axial spondyloarthritis.
    Huang Y; Deng W; Zheng S; Feng F; Huang Z; Huang Q; Guo X; Huang Z; Huang X; Pan X; Li T
    Int Immunopharmacol; 2018 Apr; 57():43-46. PubMed ID: 29471252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
    Deodhar A; Strand V; Kay J; Braun J
    Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
    Sieper J; van der Heijde D; Dougados M; Mease PJ; Maksymowych WP; Brown MA; Arora V; Pangan AL
    Ann Rheum Dis; 2013 Jun; 72(6):815-22. PubMed ID: 22772328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-radiographic axial spondyloarthritis in Tunisia: main characteristics and detailed comparison with ankylosing spondylitis.
    Ben Abdelghani K; Gzam Y; Fazaa A; Miladi S; Sellami M; Souabni L; Kassab S; Chekili S; Zakraoui L; Laater A
    Clin Rheumatol; 2021 Apr; 40(4):1361-1367. PubMed ID: 32974836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
    Baraliakos X; Kiltz U; Peters S; Appel H; Dybowski F; Igelmann M; Kalthoff L; Krause D; Menne HJ; Saracbasi-Zender E; Schmitz-Bortz E; Vigneswaran M; Braun J
    Rheumatology (Oxford); 2017 Jan; 56(1):95-102. PubMed ID: 27997346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.